In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3

Annals of Neurology

Volumn 51, Issue 1, 2002, Pages 19-27

  Chattopadhyay, Munmun ^a   Wolfe, Darren ^a   Huang, Shaohua ^a   Goss, James ^b   Glorioso, Joseph C ^b   Mata, Marina ^b   Fink, David J ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c S 520 BST ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIN 3; PYRIDOXINE; VIRUS VECTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EMBRYO; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; IN VIVO STUDY; MALE; NERVE CONDUCTION; NEUROPATHY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE CELL; SPINAL GANGLION;

ANIMALS; BEHAVIOR, ANIMAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; GANGLIA, SPINAL; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MOTOR ACTIVITY; NEURONS, AFFERENT; NEUROTROPHIN 3; PERIPHERAL NERVOUS SYSTEM DISEASES; PYRIDOXINE; RATS; SCIATIC NERVE; SIMPLEXVIRUS;

EID: 0036136733     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10061     Document Type: Article

References (39)

1. Nerve growth factor
2. The nerve growth factor 35 years later
3. Neurotrophic factors in peripheral neuropathies: Therapeutic implications
4. Nerve growth factor prevents experimental cisplatin neuropathy
5. Nerve growth factor administration protects against experimental diabetic sensory neuropathy
6. Insulin-like growth factor-1 prevents development of a vincristine neuropathy in mice
7. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy
8. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF
9. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects
10. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial
11. Gene transfer to neurons using herpes simplex virus-based vectors
12. Herpes simplex viruses and their replication
13. Herpes simplex virus latent infection in the nervous system
14. Engineering herpes simplex virus vectors for gene transfer to neurons
15. Herpes simplex virus vectors for gene transfer to the nervous system
16. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo
17. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration
18. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion
19. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion
20. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome
21. Acute sensory neuropathy-neuronopathy from pyridoxine overdose
22. Pyridoxine neuropathy in rats: Specific degeneration of sensory axons
23. Pyridoxine megavitaminosis: An analysis of the early changes induced with massive doses of vitamin B6 in rat primary sensory neurons
24. Dose-dependent expression of neuronopathy after experimental pyridoxine intoxication
25. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins
26. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1
27. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats
28. Rapid method for construction of recombinant HSV gene transfer vectors
29. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family
30. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents
31. Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory neurons
32. Dependence of developing group Ia afferents on neurotrophin-3
33. Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements
34. Severe sensory and sympathetic deficits in mice lacking neurotrophin-3
35. Expression and coexpression of trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets
36. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors
37. Entry of alpha-herpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor
38. Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alpha-herpesvirus entry
39. HveC is expressed to high levels in sensory neurons, but not in motor neurons of the rat peripheral nervous system